Visibility Isn’t Reform. Execution Is.

Healthcare is experiencing a surge of transparency. Prices are published, machine-readable files are released, data is scraped, mined, indexed, and sold. On paper, it looks like progress.

But it isn’t…….at least not yet.

Transparency makes everything uncomfortable, but execution destabilizes.

Models like Cost Plus Drugs make pricing visible, they expose the underlying economics: ingredient cost, margin, and fee. That visibility penetrates long-standing narratives about complexity and inevitability. It proves prices can be simple and known. It proves margins can be disclosed, and access doesn’t collapse.

But visibility alone doesn’t reform systems…..Until that visibility leads to action.

The same dynamic is playing out with hospital and carrier machine-readable files. Entire companies have emerged to scrape and mine this data, normalizing it, packaging it, and turning price opacity into spreadsheets and dashboards. The assumption is that if enough data exists, reform will follow.

That assumption is wrong.

Data doesn’t act. People do.

Machine-readable files make pricing visible, but visibility without action changes nothing. A plan sponsor can possess terabytes of pricing data and still run the same plan, sign the same contracts, hire the same consultants, and perpetuate the same actions.

Until someone does something different with the data, the system remains intact.

This is where the real divide appears.

Some efforts stop at exposure. They aggregate data, publish dashboards, and sell insight. That creates awareness, conversation, and alot of social media content. But awareness is not execution.

Other models take the next step with the data. They operationalize what the data reveals. They redesign networks, change contracts, reroute care, and alter incentives. They embed transparency into how claims are adjudicated, how providers are paid, and how members actually access care.

The status quot system has learned how to survive transparency, and it will survive transparency. It can tolerate disclosures, compliance files, and price lists. What it cannot absorb is precedent……real employers and real plans using data to make different decisions at scale.

Once a plan sponsor acts on the data, the paradigm shifts.

The question stops being “Do we have the data?” and becomes “Why aren’t we using it?”

Cost Plus Drugs illustrates this progression in real time, moving from price visibility to operational execution. Cuban is beginning to partner, strategically, with specific PBMs and employers to OPERATIONALIZE his platform, his model. The same lesson is being applied across healthcare. Transparency is only the starting point, not the strategy.

The greatest risk to the status quo isn’t regulation or disclosure. Those can be complied with, delayed, diluted, or outright ignored.

The real risk is comparison plus action……executing on all this transparency and information.

When plan sponsors move from seeing the data to operating differently because of it, the system doesn’t reform itself overnight…..but it DOES starting getting replaced.